National Institute for Health and Care Excellence21h
Over 1,000 people with advanced breast cancer set to benefit from new once-a-day tablet
We’ve issued final draft guidance recommending a new once-a-day tablet that is set to benefit around 1,100 people with a type ...
National Institute for Health and Care Excellence9h
NICE recommends new treatment to prevent and reduce hearing loss in people being treated for cancer
Anhydrous sodium thiosulfate, also known as Pedmarqsi and made by Norgine, is recommended in final draft guidance for preventing hearing loss caused by cisplatin chemotherapy in children from the ages ...